Search

everythinglearnresearchcommunity

for

Search:↓

Fumai Paste helps heal skin damage from chemotherapy better than magnesium sulfate.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

The treatment is safe and shows promise for metastatic breast cancer.

Vinblastine and its metabolites may cause nausea and hair loss by binding to specific receptors and could lead to better chemotherapy drugs with fewer side effects.

PLD is an effective and safer alternative for treating breast cancer.

The document concludes that scalp cooling and treatments like minoxidil can help manage hair loss from cancer therapy.

Recognizing trichoscopic features is crucial for diagnosing various hair loss conditions.

Carboplatin-paclitaxel is preferred for advanced lung cancer due to its balance of affordability and patient well-being.

Chemotherapy in the first trimester of pregnancy is risky, but in the second and third trimesters, it's generally safe with careful drug selection and timing.

Doxil is an effective, modified chemotherapy drug with a unique toxicity profile and shows promise in treating certain cancers.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Anticancer drugs are increasingly found in surface waters, and their long-term environmental effects are not well understood, requiring better testing methods.

Chemotherapy can cause various skin reactions, with hair loss being the most common, and proper diagnosis and treatment of these reactions are important.

Sorafenib is effective in treating Desmoid Tumor/Deep Fibromatosis.

Cancer therapy can cause various skin problems, including hair loss, skin darkening, painful hand-foot syndrome, and severe skin damage.

Some drugs can cause hair loss, change hair color and shape, or increase hair growth, and treatment may involve stopping the drug or using specific hair growth treatments.

The treatment combining docetaxel, cisplatin, and 5-FU is feasible and effective for advanced head and neck cancer.

Scalp cooling can reduce chemotherapy-induced hair loss and should be available in all hospitals.

Chemotherapy often causes hair loss, nail changes, and mouth issues, but these are usually manageable.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

Mitoxantrone is effective for treating acute leukemia, especially in older patients, with a lower risk of heart damage.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Losing eyelashes or eyebrows can be a sign of many different health problems and needs a careful approach to treat effectively.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Increasing ABC transporters in hair follicles may prevent chemotherapy-induced hair loss.

Gemcitabine and paclitaxel are effective and safe as first-line treatment for metastatic breast cancer.

Nurses are crucial in managing chemotherapy side effects for ovarian cancer patients to improve their quality of life.

Targeting EGFR may help reduce hair loss from chemotherapy.